Chemoinformaics analysis of 4-[2-(3-Hydroxyphenyl)ethyl]-2,6-dimethoxyphenol
| Molecular Weight | 220.356 | nRot | 1 |
| Heavy Atom Molecular Weight | 196.164 | nRig | 17 |
| Exact Molecular Weight | 220.183 | nRing | 3 |
| Solubility: LogS | -3.633 | nHRing | 2 |
| Solubility: LogP | 3.07 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 40 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 2 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 3 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 41.855 |
| nHD | 0 | BPOL | 25.813 |
| QED | 0.545 |
| Synth | 2.944 |
| Natural Product Likeliness | 1.464 |
| NR-PPAR-gamma | 0.96 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.012 |
| Pgp-sub | 0.795 |
| HIA | 0.038 |
| CACO-2 | -5.159 |
| MDCK | 0.00000979 |
| BBB | 0.006 |
| PPB | 0.931252 |
| VDSS | 0.731 |
| FU | 0.126619 |
| CYP1A2-inh | 0.87 |
| CYP1A2-sub | 0.878 |
| CYP2c19-inh | 0.031 |
| CYP2c19-sub | 0.061 |
| CYP2c9-inh | 0.099 |
| CYP2c9-sub | 0.745 |
| CYP2d6-inh | 0.148 |
| CYP2d6-sub | 0.518 |
| CYP3a4-inh | 0.107 |
| CYP3a4-sub | 0.112 |
| CL | 11.093 |
| T12 | 0.929 |
| hERG | 0.173 |
| Ames | 0.179 |
| ROA | 0.068 |
| SkinSen | 0.888 |
| Carcinogencity | 0.032 |
| EI | 0.919 |
| Respiratory | 0.399 |
| NR-Aromatase | 0.901 |
| Antiviral | Yes |
| Prediction | 0.909312 |